DATA GRAPHICS | Data Byte
European venture fundraising backslides in 2022
U.K. biotechs continued to bring in more venture capital than their European peers
March 30, 2023 7:40 PM UTC
After three years of growth, the total venture capital raised by European biotechs fell back to 2018 levels last year. U.K. companies once again raised the lion’s share of the funds.
The total venture raised by European therapeutics developers grew each year from 2018 through 2021, starting at $2.6 billion and reaching $6.4 billion, before dipping back to $2.9 billion in 2022...